Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

1.

Synergism of tapasin and human leukocyte antigens in resolving hepatitis C virus infection.

Ashraf S, Nitschke K, Warshow UM, Brooks CR, Kim AY, Lauer GM, Hydes TJ, Cramp ME, Alexander G, Little AM, Thimme R, Neumann-Haefelin C, Khakoo SI.

Hepatology. 2013 Sep;58(3):881-9. doi: 10.1002/hep.26415. Epub 2013 Jul 29.

PMID:
23532923
[PubMed - indexed for MEDLINE]
2.

A polymorphism in IL28B distinguishes exposed, uninfected individuals from spontaneous resolvers of HCV infection.

Knapp S, Warshow U, Ho KM, Hegazy D, Little AM, Fowell A, Alexander G, Thursz M, Cramp M, Khakoo SI.

Gastroenterology. 2011 Jul;141(1):320-5, 325.e1-2. doi: 10.1053/j.gastro.2011.04.005. Epub 2011 Apr 14.

PMID:
21600205
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

A comparative review of HLA associations with hepatitis B and C viral infections across global populations.

Singh R, Kaul R, Kaul A, Khan K.

World J Gastroenterol. 2007 Mar 28;13(12):1770-87. Review.

PMID:
17465466
[PubMed - indexed for MEDLINE]
Free Article
4.

Influence of HLA haplotypes on the clinical courses of individuals infected with hepatitis C virus.

Kuzushita N, Hayashi N, Moribe T, Katayama K, Kanto T, Nakatani S, Kaneshige T, Tatsumi T, Ito A, Mochizuki K, Sasaki Y, Kasahara A, Hori M.

Hepatology. 1998 Jan;27(1):240-4.

PMID:
9425943
[PubMed - indexed for MEDLINE]
5.

Divergent adaptation of hepatitis C virus genotypes 1 and 3 to human leukocyte antigen-restricted immune pressure.

Rauch A, James I, Pfafferott K, Nolan D, Klenerman P, Cheng W, Mollison L, McCaughan G, Shackel N, Jeffrey GP, Baker R, Freitas E, Humphreys I, Furrer H, Günthard HF, Hirschel B, Mallal S, John M, Lucas M, Barnes E, Gaudieri S.

Hepatology. 2009 Oct;50(4):1017-29. doi: 10.1002/hep.23101.

PMID:
19670417
[PubMed - indexed for MEDLINE]
6.

Spontaneous control of HCV is associated with expression of HLA-B 57 and preservation of targeted epitopes.

Kim AY, Kuntzen T, Timm J, Nolan BE, Baca MA, Reyor LL, Berical AC, Feller AJ, Johnson KL, Schulze zur Wiesch J, Robbins GK, Chung RT, Walker BD, Carrington M, Allen TM, Lauer GM.

Gastroenterology. 2011 Feb;140(2):686-696.e1. doi: 10.1053/j.gastro.2010.09.042. Epub 2010 Sep 24.

PMID:
20875418
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

The relation of HLA genotype to hepatitis C viral load and markers of liver fibrosis in HIV-infected and HIV-uninfected women.

Kuniholm MH, Gao X, Xue X, Kovacs A, Marti D, Thio CL, Peters MG, Greenblatt RM, Goedert JJ, Cohen MH, Minkoff H, Gange SJ, Anastos K, Fazzari M, Young MA, Strickler HD, Carrington M.

J Infect Dis. 2011 Jun 15;203(12):1807-14. doi: 10.1093/infdis/jir192.

PMID:
21606539
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Distinct assembly profiles of HLA-B molecules.

Rizvi SM, Salam N, Geng J, Qi Y, Bream JH, Duggal P, Hussain SK, Martinson J, Wolinsky SM, Carrington M, Raghavan M.

J Immunol. 2014 Jun 1;192(11):4967-76. doi: 10.4049/jimmunol.1301670. Epub 2014 Apr 30.

PMID:
24790147
[PubMed - indexed for MEDLINE]
9.

Association of human leukocyte antigen polymorphism with outcomes of hepatitis B virus infection.

Ramezani A, Hasanjani Roshan MR, Kalantar E, Eslamifar A, Banifazl M, Taeb J, Aghakhani A, Gachkar L, Velayati AA.

J Gastroenterol Hepatol. 2008 Nov;23(11):1716-21. doi: 10.1111/j.1440-1746.2008.05482.x. Epub 2008 Aug 28.

PMID:
18761557
[PubMed - indexed for MEDLINE]
10.

IL28B, HLA-C, and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a European Cohort: a cross-sectional study.

Suppiah V, Gaudieri S, Armstrong NJ, O'Connor KS, Berg T, Weltman M, Abate ML, Spengler U, Bassendine M, Dore GJ, Irving WL, Powell E, Hellard M, Riordan S, Matthews G, Sheridan D, Nattermann J, Smedile A, Müller T, Hammond E, Dunn D, Negro F, Bochud PY, Mallal S, Ahlenstiel G, Stewart GJ, George J, Booth DR; International Hepatitis C Genetics Consortium (IHCGC).

PLoS Med. 2011 Sep;8(9):e1001092. doi: 10.1371/journal.pmed.1001092. Epub 2011 Sep 13.

PMID:
21931540
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

HLA-Cw*04 and hepatitis C virus persistence.

Thio CL, Gao X, Goedert JJ, Vlahov D, Nelson KE, Hilgartner MW, O'Brien SJ, Karacki P, Astemborski J, Carrington M, Thomas DL.

J Virol. 2002 May;76(10):4792-7.

PMID:
11967296
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Virological and immunological determinants of intrahepatic virus-specific CD8+ T-cell failure in chronic hepatitis C virus infection.

Neumann-Haefelin C, Timm J, Spangenberg HC, Wischniowski N, Nazarova N, Kersting N, Roggendorf M, Allen TM, Blum HE, Thimme R.

Hepatology. 2008 Jun;47(6):1824-36. doi: 10.1002/hep.22242.

PMID:
18454507
[PubMed - indexed for MEDLINE]
13.

Consistent beneficial effects of killer cell immunoglobulin-like receptor 2DL3 and group 1 human leukocyte antigen-C following exposure to hepatitis C virus.

Knapp S, Warshow U, Hegazy D, Brackenbury L, Guha IN, Fowell A, Little AM, Alexander GJ, Rosenberg WM, Cramp ME, Khakoo SI.

Hepatology. 2010 Apr;51(4):1168-75. doi: 10.1002/hep.23477.

PMID:
20077564
[PubMed - indexed for MEDLINE]
14.

Human leukocyte antigen-associated sequence polymorphisms in hepatitis C virus reveal reproducible immune responses and constraints on viral evolution.

Timm J, Li B, Daniels MG, Bhattacharya T, Reyor LL, Allgaier R, Kuntzen T, Fischer W, Nolan BE, Duncan J, Schulze zur Wiesch J, Kim AY, Frahm N, Brander C, Chung RT, Lauer GM, Korber BT, Allen TM.

Hepatology. 2007 Aug;46(2):339-49.

PMID:
17559151
[PubMed - indexed for MEDLINE]
15.

Effect of human leukocyte antigen class I and II alleles on hepatitis C viral load among chronic hepatitis C patients in Southern Taiwan.

Tseng KC, Tseng CW, Hsieh YH, Chang CK, Lai NS, Hung TH, Chang TT.

Hum Immunol. 2013 Aug;74(8):978-82. doi: 10.1016/j.humimm.2013.04.023. Epub 2013 Apr 27.

PMID:
23628398
[PubMed - indexed for MEDLINE]
16.

Tapasin modification on the intracellular epitope HBcAg18-27 enhances HBV-specific CTL immune response and inhibits hepatitis B virus replication in vivo.

Chen X, Tang Y, Zhang Y, Zhuo M, Tang Z, Yu Y, Zang G.

Lab Invest. 2014 May;94(5):478-90. doi: 10.1038/labinvest.2014.6. Epub 2014 Mar 10.

PMID:
24614195
[PubMed - indexed for MEDLINE]
17.

Patient HLA-DRB1* and -DQB1* allele and haplotype association with hepatitis C virus persistence and clearance.

Ali L, Mansoor A, Ahmad N, Siddiqi S, Mazhar K, Muazzam AG, Qamar R, Khan KM.

J Gen Virol. 2010 Aug;91(Pt 8):1931-8. doi: 10.1099/vir.0.018119-0. Epub 2010 Apr 14.

PMID:
20392899
[PubMed - indexed for MEDLINE]
Free Article
18.

Human leukocyte antigen class I alleles can predict response to pegylated interferon/ribavirin therapy in chronic hepatitis C Egyptian patients.

Farag RE, Arafa MM, El-Etreby S, Saudy NS, Eldeek BS, El-Alfy HA, Goda IF, Ali RM.

Arch Iran Med. 2013 Feb;16(2):68-73. doi: 013162/AIM.004.

PMID:
23360626
[PubMed - indexed for MEDLINE]
Free Article
19.

Association between human leukocyte antigen class I and II alleles and hepatitis C virus infection in high-risk hemodialysis patients awaiting kidney transplantation.

Grimaldi V, Sommese L, Picascia A, Casamassimi A, Cacciatore F, Renda A, De Rosa P, Montesano ML, Sabia C, Fiorito C, De Iorio G, Napoli C.

Hum Immunol. 2013 Dec;74(12):1629-32. doi: 10.1016/j.humimm.2013.08.008. Epub 2013 Aug 20.

PMID:
23974050
[PubMed - indexed for MEDLINE]
20.

Effect of killer immunoglobulin-like receptors in the response to combined treatment in patients with chronic hepatitis C virus infection.

Vidal-Castiñeira JR, López-Vázquez A, Díaz-Peña R, Alonso-Arias R, Martínez-Borra J, Pérez R, Fernández-Suárez J, Melón S, Prieto J, Rodrigo L, López-Larrea C.

J Virol. 2010 Jan;84(1):475-81. doi: 10.1128/JVI.01285-09. Epub .

PMID:
19846535
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk